Fresenius Kabi standalone Dec '13 sales at Rs 84.66 crore Fresenius Kabi Oncology has reported a standalone sales turnover of Rs 84.66 crore and a net loss of Rs 63.63 crore for the quarter ended ...
Fresenius Kabi, an operating company of Fresenius, announced today it has introduced Calcitonin Salmon Injection, USP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback